CorMedix surges after better-than-expected Q2 results
CorMedix Inc. (NASDAQ: CRMD) surged 23.6% after the company reported better-than-expected second-quarter financial results.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.